National Guideline Clearinghouse | Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle–brachial index in adults: U.S. Preventive Services Task Force recommendation statement.

full-text ►
National Guideline Clearinghouse | Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle–brachial index in adults: U.S. Preventive Services Task Force recommendation statement.

December 16, 2013

---

New This Week

Guideline Title Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle–brachial index in adults: U.S. Preventive Services Task Force recommendation statement. Bibliographic Source(s) U.S. Preventive Services Task Force. Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013 Sep 3;159(5):342-8. [17 references] PubMed  Guideline Status This is the current release of the guideline. This guideline updates a previous version: U.S. Preventive Services Task Force. Screening for peripheral arterial disease: recommendation statement. Am Fam Physician. 2006 Feb 1;73(3):497-500 Screening for peripheral artery disease and c... [Ann Intern Med. 2013] - PubMed - NCBI Ann Intern Med. 2013 Sep 3;159(5):342-8. doi: 10.7326/0003-4819-159-5-201309030-00008. Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement. Moyer VA; U.S. Preventive Services Task Force. Collaborators (17) Abstract DESCRIPTION: Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for peripheral artery disease (PAD). METHODS: The USPSTF reviewed the evidence on the use of resting ankle-brachial index (ABI) as a screening test for PAD or as a risk predictor for cardiovascular disease (CVD). The review focused on resting ABI as the sole screening method; the diagnostic performance of ABI testing in primary care populations, unselected populations, and asymptomatic populations; the predictive value of ABI testing for major CVD outcomes in primary care or unselected populations; and the effect of treatment on general CVD and PAD-specific morbidity in patients with asymptomatic or minimally symptomatic PAD. POPULATION: This recommendation applies to asymptomatic adults who do not have a known diagnosis of PAD, CVD, severe chronic kidney disease, or diabetes. RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for PAD and CVD risk assessment with the ABI in adults. (I statement). Summary for patients in Ann Intern Med. 2013 Sep 3;159(5):I-28. PMID:   24026320   [PubMed - indexed for MEDLINE]